However, compounds C9 and C9a failed to inhibit such phosphorylation events in A549 cells (S6B Fig, lanes 2 and 3), suggesting that compounds C9 and C9a inhibit growth of lung cancer cells not through targeting CDKs rather than a direct consequence of PRMT5 inhibition. Here, PRMT5 is linked to lung carcinoma.